POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 130 participants.

Also called NCT03508219

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
  • Balton Sp.zo.o. Registry lists this organization as a collaborator
  • Cardialysis BV Registry lists this organization as a collaborator
  • ECRI bv Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03508219
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
France, Italy, Poland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03508219. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-10 (actual); primary completion 2021-04-15 (actual). Results posted on 2025-09-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
Acronym
POLBOS-LM
Condition
Coronary Stenosis
Intervention (Device)
BiOSS LIM C
Lead sponsor
ECRI bv (class: industry)
Collaborator
Cardialysis BV (class: industry)
Collaborator
Balton Sp.zo.o. (class: industry)

Record details

Record id
cardio:ct-nct03508219
Content hash
727a7992c3dae161bf56cd1abe115e5152326041c3b645594545179c1d1cd6df